Latest filing published 21 Dec 2021 for Clinigence Holdings, Inc., €452k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mark Fawcett: trading record in brief
Mark Fawcett, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Astrana Health, Inc. and Nutex Health, Inc. Over a trading history stretching from 11 June 2019 to 28 January 2021, the count stands at 3 filings.
Purchases make up the whole of the open-market record (1 purchase, €125k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 option exercise.
The newest entry dates from 21 December 2021: a transaction of €452k, in Nutex Health, Inc. The latest purchase dates back some time: it was published 2,706 days ago, on 13 June 2019. Filings reach the SEC (Form 4) feed a median of 15 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Mark Fawcett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 268,263 shares@ US$2.04100.0% of flowCommon StockSEC:0001486189-21-000014:0
1 of 1 declaration
